BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Yingying Lu, Jianliang Zhang, Jiaming Qian. The Effect of Emodin on VEGF Receptors in Human Colon Cancer CellsCancer Biotherapy and Radiopharmaceuticals 2008; 23(2): 222 doi: 10.1089/cbr.2007.0425
Lalit Mohan Negi, Manu Jaggi, Vidushi Joshi, Kar Ronodip, Sushama Talegaonkar. Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancerInternational Journal of Biological Macromolecules 2015; 73: 222 doi: 10.1016/j.ijbiomac.2014.11.026
Gianluigi Giannelli, Concetta Sgarra, Letizia Porcelli, Amalia Azzariti, Salvatore Antonaci, Angelo Paradiso. EGFR and VEGFR as potential target for biological therapies in HCC cellsCancer Letters 2008; 262(2): 257 doi: 10.1016/j.canlet.2007.12.001
Stefan Langhammer, Robert Koban, Constanze Yue, Heinz Ellerbrok. Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa™)Antiviral Research 2011; 89(1): 64 doi: 10.1016/j.antiviral.2010.11.006
Csilla Hegedüs, Krisztina Truta-Feles, Géza Antalffy, György Várady, Katalin Német, Csilla Özvegy-Laczka, György Kéri, László Őrfi, Gergely Szakács, Jeffrey Settleman, András Váradi, Balázs Sarkadi. Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistanceBiochemical Pharmacology 2012; 84(3): 260 doi: 10.1016/j.bcp.2012.04.010
Csilla Hegedüs, Tamás Hegedüs, Balázs Sarkadi. Resistance to Targeted ABC Transporters in CancerResistance to Targeted Anti-Cancer Therapeutics 2015; 4: 209 doi: 10.1007/978-3-319-09801-2_9
Amalia Azzariti, Letizia Porcelli, Giuliana Gatti, Angelo Nicolin, Angelo Paradiso. Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cellsBiochemical Pharmacology 2008; 75(5): 1035 doi: 10.1016/j.bcp.2007.11.018
Rahul V. Patel, Bhupendra M. Mistry, Riyaz Syed, Nikhil M. Parekh, Han-Seung Shin. Pyrrolo[1,2-a]azepines Coupled with Benzothiazole and Fluorinated Aryl Thiourea Scaffolds as Promising Antioxidant and Anticancer AgentsAnti-Cancer Agents in Medicinal Chemistry 2019; 19(15): 1855 doi: 10.2174/1871520619666190820151043
A Azzariti, G Bocci, L Porcelli, A Fioravanti, P Sini, G M Simone, A E Quatrale, P Chiarappa, A Mangia, S Sebastian, D Del Bufalo, M Del Tacca, A Paradiso. Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancerBritish Journal of Cancer 2011; 104(5): 769 doi: 10.1038/bjc.2011.21
Lalit Mohan Negi, Sushama Talegaonkar, Manu Jaggi, Anita Kamra Verma, Ritu Verma, Sheetal Dobhal, Vijay Kumar. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigationColloids and Surfaces B: Biointerfaces 2014; 123: 600 doi: 10.1016/j.colsurfb.2014.09.062
Rahul V. Patel, Bhupendra M. Mistry, Riyaz Syed, Nikhil M. Parekh, Han‐Seung Shin. Sulfonylpiperazines based on a flavone as antioxidant and cytotoxic agentsArchiv der Pharmazie 2019; 352(9): 1900051 doi: 10.1002/ardp.201900051
Amalia Azzariti, Letizia Porcelli, Grazia M. Simone, Anna E. Quatrale, Nicola A. Colabufo, Francesco Berardi, Roberto Perrone, Massimo Zucchetti, Maurizio D’Incalci, Jian Ming Xu, Angelo Paradiso. Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequencesCancer Chemotherapy and Pharmacology 2010; 65(2): 335 doi: 10.1007/s00280-009-1039-0